Recently, Chengdu Jinshi Technology Co., Ltd. was selected into the list of innovative small and medium-sized enterprises in Sichuan Province. The list was issued by the Sichuan Provincial Department of Economy and Information Technology, in accordance with the requirements of the Ministry of Industry and Information Technology''s "Interim Measures for the gradient Cultivation Management of high-quality smes" (Ministry of Industry and Information Technology Enterprise (2022) No. 63) and the "Implementation Plan for the gradient cultivation Management of high-quality smes in Sichuan Province", and was reviewed by the Municipal (prefecture) Economic and Information Bureau according to procedures and finally determined.

In this selection, science and technology has been successfully elected with excellent research and development strength and excellent innovation ability. The company was established in 2017 and has successively set up a research and development team including senior experts in biochemistry, integrated circuits, materials, MEMS, organic synthesis, algorithms and other directions, covering all professional fields needed for the development of the fourth-generation gene sequencer. By the end of 2023, it will lead the commercialization of synthetic nanopore sequencing platforms worldwide.

After 6 years of accumulation, the company now has an elite team of 116 people, of which the proportion of master and doctoral students has reached more than 60%, and the core members have been selected as the innovation and entrepreneurship team of Emei Plan in Sichuan Province, with a high level of research and development strength.

Today is technology will take this honor as an opportunity to continue to invest in R & D and innovation, and enable China''s independent intellectual property rights of nanopore gene sequencing technology to scientific research, clinical, inspection and quarantine, judicial, and strive to ultimately realize the grand vision of "making gene sequencing a routine means of precision medicine and improving human health."